메뉴 건너뛰기




Volumn 8, Issue 1, 2016, Pages

LEADER 7: Cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differ

Author keywords

Cardiovascular outcome trial; External validity; Generalizability; Heterogeneity; Type 2 diabetes

Indexed keywords


EID: 84971501056     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/s13098-016-0153-5     Document Type: Article
Times cited : (9)

References (19)
  • 2
    • 84901768284 scopus 로고    scopus 로고
    • Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes
    • 1:CAS:528:DC%2BC2cXpslCrsb8%3D 24910232
    • Holman RR, Sourij H, Califf RM. Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes. Lancet. 2014;383:2008-17.
    • (2014) Lancet , vol.383 , pp. 2008-2017
    • Holman, R.R.1    Sourij, H.2    Califf, R.M.3
  • 3
    • 84874174557 scopus 로고    scopus 로고
    • External validity of randomized controlled trials of glycaemic control and vascular disease: How representative are participants?
    • Scottish Diabetes Research Network Epidemiology Group 1:STN:280:DC%2BC3s%2FlvF2gsQ%3D%3D 23075287
    • Saunders C, Byrne CD, Guthrie B, Lindsay RS, McKnight JA, Philip S, Sattar N, Walker JJ, Wild SH, Scottish Diabetes Research Network Epidemiology Group. External validity of randomized controlled trials of glycaemic control and vascular disease: how representative are participants? Diabet Med. 2013;30:300-8.
    • (2013) Diabet Med , vol.30 , pp. 300-308
    • Saunders, C.1    Byrne, C.D.2    Guthrie, B.3    Lindsay, R.S.4    McKnight, J.A.5    Philip, S.6    Sattar, N.7    Walker, J.J.8    Wild, S.H.9
  • 4
    • 84877889323 scopus 로고    scopus 로고
    • A systematic review of the factors influencing African American's participation in cancer clinical trials
    • Rivers D, August EM, Sehovic I, Lee Green B, Quin GP. A systematic review of the factors influencing African American's participation in cancer clinical trials. Contem Clin Trials. 2013;35:13-32.
    • (2013) Contem Clin Trials. , vol.35 , pp. 13-32
    • Rivers, D.1    August, E.M.2    Sehovic, I.3    Lee Green, B.4    Quin, G.P.5
  • 5
    • 84871906245 scopus 로고    scopus 로고
    • Prevalence of diabetes treatment effect modifiers: The external validity of trials of older adults
    • 23238312 3531895
    • Weiss CO, Boyd CM, Wolff JL, Leff B. Prevalence of diabetes treatment effect modifiers: the external validity of trials of older adults. Aging Clin Exp Res. 2012;24:370-6.
    • (2012) Aging Clin Exp Res. , vol.24 , pp. 370-376
    • Weiss, C.O.1    Boyd, C.M.2    Wolff, J.L.3    Leff, B.4
  • 6
    • 17844393639 scopus 로고    scopus 로고
    • Influence of clinical trial enrollment on the quality of care and outcomes for patients with non-ST-segment elevation acute coronary syndromes
    • 15864236
    • Kandzari DE, Roe MT, Chen AY, Lytle BL, Pollack CV Jr, Harrington RA, Ohman EM, Gibler WB, Peterson ED. Influence of clinical trial enrollment on the quality of care and outcomes for patients with non-ST-segment elevation acute coronary syndromes. Am Heart J. 2005;149:474-81.
    • (2005) Am Heart J , vol.149 , pp. 474-481
    • Kandzari, D.E.1    Roe, M.T.2    Chen, A.Y.3    Lytle, B.L.4    Pollack, C.V.5    Harrington, R.A.6    Ohman, E.M.7    Gibler, W.B.8    Peterson, E.D.9
  • 7
    • 0034712491 scopus 로고    scopus 로고
    • Subgroup analysis and other (mis)uses of baseline data in clinical trials
    • 1:STN:280:DC%2BD3c3gsF2lsg%3D%3D 10744093
    • Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet. 2000;355:1064-9.
    • (2000) Lancet , vol.355 , pp. 1064-1069
    • Assmann, S.F.1    Pocock, S.J.2    Enos, L.E.3    Kasten, L.E.4
  • 8
    • 84874338510 scopus 로고    scopus 로고
    • Centre selection for clinical trials and the generalisability of results; A mixed methods study
    • 1:CAS:528:DC%2BC3sXjslChsL4%3D 23451055 3579829
    • Gheorghe A, Roberts TE, Ives JC, Fletcher BR, Calvert M. Centre selection for clinical trials and the generalisability of results; a mixed methods study. PLoS One. 2013;8:e56560.
    • (2013) PLoS One , vol.8 , pp. e56560
    • Gheorghe, A.1    Roberts, T.E.2    Ives, J.C.3    Fletcher, B.R.4    Calvert, M.5
  • 10
    • 75149180515 scopus 로고    scopus 로고
    • Standards of Medical Care in Diabetes - 2010
    • American Diabetes Association
    • American Diabetes Association. Standards of Medical Care in Diabetes - 2010. Diabetes Care. 2010;33:S4-10.
    • (2010) Diabetes Care , vol.33 , pp. S4-S10
  • 11
    • 77955382172 scopus 로고    scopus 로고
    • Assessing and reporting heterogeneity in treatment affects in clinical trials; A proposal
    • Kent DM, Rothwell PM, Ioannidis JPA, Altman DG, Hayward RA. Assessing and reporting heterogeneity in treatment affects in clinical trials; a proposal. Trials. 2011;11:85.
    • (2011) Trials. , vol.11 , pp. 85
    • Kent, D.M.1    Rothwell, P.M.2    Ioannidis, J.P.A.3    Altman, D.G.4    Hayward, R.A.5
  • 12
    • 70349224483 scopus 로고    scopus 로고
    • Subgroup analyses in randomized controlled trials: The need for risk stratification in kidney transplantation
    • 1:STN:280:DC%2BD1MnjsFagug%3D%3D 19764948 2997518
    • Wagner M, Balk EM, Kent DM, Kasiske BL, Ekberg H. Subgroup analyses in randomized controlled trials: the need for risk stratification in kidney transplantation. Am J Transplant. 2009;9:2217-22.
    • (2009) Am J Transplant , vol.9 , pp. 2217-2222
    • Wagner, M.1    Balk, E.M.2    Kent, D.M.3    Kasiske, B.L.4    Ekberg, H.5
  • 13
    • 84866268783 scopus 로고    scopus 로고
    • Management of hyperglycemia in type 2 diabetes: A patient-centered approach
    • American Diabetes Association (ADA) European Association for the Study of Diabetes (EASD) 1:CAS:528:DC%2BC38Xps1Kitb4%3D 22517736 3357214
    • Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR, American Diabetes Association (ADA), European Association for the Study of Diabetes (EASD). Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Diabetes Care. 2012;35:1364-79.
    • (2012) Diabetes Care , vol.35 , pp. 1364-1379
    • Inzucchi, S.E.1    Bergenstal, R.M.2    Buse, J.B.3    Diamant, M.4    Ferrannini, E.5    Nauck, M.6    Peters, A.L.7    Tsapas, A.8    Wender, R.9    Matthews, D.R.10
  • 14
    • 84902294864 scopus 로고    scopus 로고
    • Clinical Practice Recommendation
    • American Diabetes Association
    • American Diabetes Association. Clinical Practice Recommendation. Diabetes Care. 2014;37:S1.
    • (2014) Diabetes Care , vol.37 , pp. S1
  • 16
    • 84919427890 scopus 로고    scopus 로고
    • Predicting the effect of blood pressure lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: Results from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation
    • 25312436
    • van der Leeuw J, Visseren FL, Woodward M, Zoungas S, Kengne AP, van der Graaf Y, Glasziou P, Hamet P, MacMahon S, Poulter N, Grobbee DE, Chalmers J. Predicting the effect of blood pressure lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: results from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation. Hypertension. 2015;65:115-21.
    • (2015) Hypertension , vol.65 , pp. 115-121
    • Van Der Leeuw, J.1    Visseren, F.L.2    Woodward, M.3    Zoungas, S.4    Kengne, A.P.5    Van Der Graaf, Y.6    Glasziou, P.7    Hamet, P.8    MacMahon, S.9    Poulter, N.10    Grobbee, D.E.11    Chalmers, J.12
  • 17
    • 85018214585 scopus 로고    scopus 로고
    • Effect of intensive versus standard blood glucose control in patients with type 2 diabetes in different regions of the world: Systematic review and meta-analysis of randomized controlled trials
    • 25944874 4599400
    • Sardar P, Udell JA, Chatterjee S, Bansilal S, Mukherjee D, Farkouh ME. Effect of intensive versus standard blood glucose control in patients with type 2 diabetes in different regions of the world: systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc. 2015;4:e001577.
    • (2015) J Am Heart Assoc. , vol.4 , pp. e001577
    • Sardar, P.1    Udell, J.A.2    Chatterjee, S.3    Bansilal, S.4    Mukherjee, D.5    Farkouh, M.E.6
  • 18
    • 84924740545 scopus 로고    scopus 로고
    • Holman RR; TECOS Executive Committee. Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)
    • 1:CAS:528:DC%2BC2MXktVems7c%3D 25600421
    • Bethel MA, Green JB, Milton J, Tajar A, Engel SS, Califf RM. Holman RR; TECOS Executive Committee. Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS). Diabetes Obes Metab. 2015;17:395-402.
    • (2015) Diabetes Obes Metab , vol.17 , pp. 395-402
    • Bethel, M.A.1    Green, J.B.2    Milton, J.3    Tajar, A.4    Engel, S.S.5    Califf, R.M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.